Healthcare provider profile · identity verified

Michelle M Russell, DO

Family Practice · CENTERVILLE, OH · NPI 1366428476

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	721	197
Levothyroxine Sodium	Levothyroxine Sodium	627	156
Lisinopril	Lisinopril	390	111
Rosuvastatin Calcium	Rosuvastatin Calcium	326	98
Losartan Potassium	Losartan Potassium	267	72
Omeprazole	Omeprazole	217	62
Metoprolol Succinate	Metoprolol Succinate	208	57
Metformin Hcl	Metformin Hcl	205	55
Gabapentin	Gabapentin	193	49
Amlodipine Besylate	Amlodipine Besylate	184	52
Escitalopram Oxalate	Escitalopram Oxalate	162	45
Pantoprazole Sodium	Pantoprazole Sodium	144	43
Ezetimibe	Ezetimibe	126	37
Simvastatin	Simvastatin	125	31
Bupropion Xl	Bupropion Hcl	122	34
Ozempic	Semaglutide	108	20
Pravastatin Sodium	Pravastatin Sodium	99	23
Duloxetine Hcl	Duloxetine Hcl	95	25
Sertraline Hcl	Sertraline Hcl	86	29
Montelukast Sodium	Montelukast Sodium	83	25
Meloxicam	Meloxicam	76	28
Trazodone Hcl	Trazodone Hcl	76	21
Carvedilol	Carvedilol	72	24
Metoprolol Tartrate	Metoprolol Tartrate	72	18
Farxiga	Dapagliflozin Propanediol	70	26
Methocarbamol	Methocarbamol	70	20
Clopidogrel	Clopidogrel Bisulfate	69	20
Tramadol Hcl	Tramadol Hcl	67	18
Alprazolam	Alprazolam	66	13
Lorazepam	Lorazepam	64	20
Amitriptyline Hcl	Amitriptyline Hcl	63	13
Synthroid	Levothyroxine Sodium	62	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	19
Citalopram Hbr	Citalopram Hydrobromide	60	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	13
Hydrochlorothiazide	Hydrochlorothiazide	55	18
Tamsulosin Hcl	Tamsulosin Hcl	55	16
Eliquis	Apixaban	52	14
Buspirone Hcl	Buspirone Hcl	51	13
Furosemide	Furosemide	50	16
Albuterol Sulfate Hfa	Albuterol Sulfate	49	21
Ibuprofen	Ibuprofen	49	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	12
Allopurinol	Allopurinol	44	13
Atenolol	Atenolol	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	12
Fenofibrate	Fenofibrate Nanocrystallized	41	13
Alendronate Sodium	Alendronate Sodium	39	14
Mounjaro	Tirzepatide	39	suppressed
Mirtazapine	Mirtazapine	38	13
Doxycycline Hyclate	Doxycycline Hyclate	36	31
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	11
Celecoxib	Celecoxib	35	11
Potassium Chloride	Potassium Chloride	35	suppressed
Aripiprazole	Aripiprazole	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Glipizide	Glipizide	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	12
Nifedipine Er	Nifedipine	32	suppressed
Valsartan	Valsartan	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Jardiance	Empagliflozin	27	11
Azithromycin	Azithromycin	26	26
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	22
Clonazepam	Clonazepam	24	suppressed
Methylprednisolone	Methylprednisolone	24	23
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Naproxen	Naproxen	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Prednisone	Prednisone	20	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Kerendia	Finerenone	19	suppressed
Prolia	Denosumab	18	11
Repatha Sureclick	Evolocumab	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Famotidine	Famotidine	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Linzess	Linaclotide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Nadolol	Nadolol	17	suppressed
Fluconazole	Fluconazole	16	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Dapagliflozin	Dapagliflozin Propanediol	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Diazepam	Diazepam	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Finasteride	Finasteride	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Temazepam	Temazepam	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Albuterol Sulfate	Albuterol Sulfate	11	suppressed
Baclofen	Baclofen	11	suppressed
Dilantin	Phenytoin Sodium Extended	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Nystatin	Nystatin	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error